Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment

Oeckl, Patrick, Halbgebauer, Steffen, Anderl-Straub, Sarah, Steinacker, Petra, Huss, André M., Neugebauer, Hermann, von Arnim, Christine A.F., Diehl-Schmid, Janine, Grimmer, Timo, Kornhuber, Johannes, Lewczuk, Piotr, Danek, Adrian, Consortium for Frontotemporal Lobar Degeneration German, Ludolph, Albert C., Otto, Markus · 2019 · Journal of Alzheimer’s Disease

Abstract

Reliable blood biomarkers for Alzheimer's disease (AD) are missing. We measured astroglial GFAP in patients with AD (n = 28), frontotemporal dementia (bvFTD, n = 35), Parkinson's disease (n = 11), Lewy body dementias (n = 19), and controls (n = 34). Serum GFAP was increased in AD (p < 0.001) and DLB/PDD (p < 0.01), and cerebrospinal fluid GFAP was increased in all neurodegenerative diseases (p < 0.001). Serum GFAP correlated with the Mini-Mental State Examination score (r= -0.42, p < 0.001) and might be a follow-up marker in clinical trials. Sensitivity and specificity of serum GFAP for AD versus bvFTD was 89% and 79% and might be the first blood biomarker in the differential diagnosis of AD and bvFTD.

Overview

Integrity signals

Registry

Crossref · 10.3233/jad-180325

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 27 references

Cited by

See all 345

Metadata

Authors
Oeckl, P., Halbgebauer, S., Anderl-Straub, S., Steinacker, P., Huss, A. M., Neugebauer, H., von Arnim, C. A. F., Diehl-Schmid, J., Grimmer, T., Kornhuber, J., Lewczuk, P., Danek, A., Consortium for Frontotemporal Lobar Degeneration German, Ludolph, A. C., & Otto, M.
Affiliations
  • University Hospital Ulm (DE)
  • Department of Neurology, Ulm University Hospital, Ulm, Germany
  • Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Technical University of Munich, München, Germany
  • TUM Klinikum (DE)
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • Medical University of Białystok (PL)
  • LMU Klinikum (DE)
Corresponding author
Otto, Markus
Venue
Journal of Alzheimer’s Disease
Published
2018-12-24
Volume
67
Issue
2
Pages
481-488
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W2910535142
Cited by
345
References
27
Citations by year
2026: 29 · 2025: 67 · 2024: 65 · 2023: 52 · 2022: 61 · 2021: 46 · 2020: 19 · 2019: 5
FWCI
13.71
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Alzheimer s Disease (publishedVersion)
  • PubMed (publishedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
glial fibrillary acidic protein, serum biomarkers
MeSH terms
Mental Status and Dementia Tests, Aged, Alzheimer Disease, Diagnosis, Differential, Female, Glial Fibrillary Acidic Protein, Humans, Male, Middle Aged, Parkinson Disease, Pilot Projects, Sensitivity and Specificity, Biomarkers, Lewy Body Disease, Frontotemporal Dementia, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment. https://app.cochat.ai/papers/10.3233/jad-180325
The paper
Oeckl, P., Halbgebauer, S., Anderl-Straub, S., Steinacker, P., Huss, A. M., Neugebauer, H., von Arnim, C. A. F., Diehl-Schmid, J., Grimmer, T., Kornhuber, J., Lewczuk, P., Danek, A., Consortium for Frontotemporal Lobar Degeneration German, Ludolph, A. C., & Otto, M. (2019). Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-180325

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.